- Gluconorm VG 0.5 Tablet provides triple mechanism glucose control by targeting insulin secretion, insulin sensitivity, and carbohydrate absorption simultaneously.
- This formulation improves fasting and post-meal sugar levels, ensuring better overall glycaemic control.
- Gluconorm VG 0.5 Tablet helps reduce glucose fluctuations, maintaining more stable daily blood sugar patterns.
- Convenient combination therapy reduces the pill burden compared to taking separate medicines.
- Supports long-term diabetes management by helping improve HbA1c levels when used regularly.
- Addresses multiple metabolic pathways, making it useful in progressive type 2 diabetes requiring intensified therapy.
- Gluconorm VG 0.5 Tablet is effective in managing blood sugar levels when lifestyle changes alone are insufficient.
- This medication is suitable for patients who require a comprehensive approach to diabetes management.
Gluconorm VG 0.5 Tablet - Strip of 10
Prescription Required
Compositions : Glimepiride 0.5mg + Metformin 500mg + Voglibose 0.2mg
₹78.49
(Incl. GST)
MRP :
(Incl. GST)
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Lupin Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Gluconorm VG 0.5 Tablet is a comprehensive pharmaceutical formulation designed specifically for the management of type 2 diabetes mellitus. This innovative medication combines three well-established anti-diabetic agents, each with distinct and complementary mechanisms of action, aimed at improving blood glucose control in patients who struggle with multiple metabolic defects contributing to poor glycaemic control. The key components of Gluconorm VG 0.5 Tablet include Glimepiride, Metformin, and Voglibose. Glimepiride is a third-generation sulfonylurea that effectively stimulates insulin secretion from functional pancreatic beta cells. By binding to sulfonylurea receptors on the membranes of pancreatic beta cells, Gluconorm VG 0.5 Tablet facilitates the closure of ATP-sensitive potassium channels, leading to membrane depolarization, calcium influx, and subsequent insulin release. This action primarily aids in lowering both fasting and postprandial blood glucose levels. Metformin, another crucial ingredient in Gluconorm VG 0.5 Tablet, belongs to the biguanide class and is recognized as a first-line treatment for type 2 diabetes. It works by reducing hepatic gluconeogenesis, enhancing peripheral insulin sensitivity, and improving glucose utilization in muscle tissue. Unlike sulfonylureas, Metformin does not stimulate insulin secretion, thus presenting a low independent risk of hypoglycaemia when used alone. The third component, Voglibose, is an alpha-glucosidase inhibitor that operates in the small intestine by inhibiting enzymes responsible for carbohydrate breakdown. This mechanism delays glucose absorption after meals, significantly reducing postprandial blood glucose excursions. The combination of these three agents in Gluconorm VG 0.5 Tablet is particularly beneficial as it addresses three major contributors to hyperglycaemia: inadequate insulin secretion, insulin resistance, and excessive post-meal glucose absorption. Gluconorm VG 0.5 Tablet is typically prescribed when lifestyle modifications and simpler anti-diabetic regimens fail to achieve desired glycaemic targets, making it an essential option for effective diabetes management.
Product Details
Uses & Benefits
How Gluconorm VG 0.5 Tablet works
Gluconorm VG 0.5 Tablet works through three complementary anti-diabetic mechanisms that enhance glycaemic control.
- Glimepiride stimulates pancreatic beta cells to release insulin by closing ATP-sensitive potassium channels, which increases insulin availability.
- Metformin reduces hepatic glucose production, improves peripheral insulin sensitivity, and enhances glucose uptake by skeletal muscle.
- Voglibose inhibits intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and reducing postprandial glucose absorption.
- Together, these actions improve fasting glucose levels and long-term glycaemic control.
How to use Gluconorm VG 0.5 Tablet
- Gluconorm VG 0.5 Tablet should be taken exactly as prescribed by a healthcare professional.
- This medication is usually taken with meals to minimize gastrointestinal discomfort.
- Swallow the tablet whole with a sufficient amount of water; do not chew or crush it.
- Do not skip meals while taking Gluconorm VG 0.5 Tablet to maintain stable blood sugar levels.
- Maintain regular meal timing to optimize the effectiveness of this therapy.
- Monitor blood sugar levels regularly to assess the effectiveness of Gluconorm VG 0.5 Tablet.
- The daily dose may vary based on individual blood glucose levels and clinical response; follow your doctor's recommendations closely.
- Consult your healthcare provider for any adjustments in dosage or treatment duration based on your condition.
Lifestyle Advice
- Avoid skipping meals while taking Gluconorm VG 0.5 Tablet to maintain stable blood sugar levels throughout the day.
- Incorporate a balanced diet rich in whole grains, vegetables, and lean proteins to support overall health and diabetes management.
- Engage in regular physical activity to enhance insulin sensitivity and improve glycaemic control alongside medication use.
- Monitor HbA1c levels regularly to assess long-term blood sugar control and adjust treatment as necessary.
- Carry a source of glucose for immediate relief in case of hypoglycaemia symptoms such as dizziness or sweating.
Safety Advice
Side Effects
Side Effects
- Common side effects of Gluconorm VG 0.5 Tablet include hypoglycaemia (low blood sugar), especially if meals are delayed or missed.
- Mild abdominal discomfort may occur during treatment initiation or dose adjustment.
- Flatulence is common due to delayed carbohydrate digestion caused by Voglibose.
- Nausea is usually mild and often improves over time as the body adjusts to the medication.
- Diarrhoea may frequently occur during early treatment with Metformin.
- Uncommon side effects include temporary loss of appetite and a metallic taste occasionally associated with Metformin use.
- Mild dizziness may occur, particularly during fluctuations in blood glucose levels.
- Serious side effects requiring immediate medical attention include severe hypoglycaemia (characterized by sweating, confusion, tremors) and lactic acidosis (indicated by severe weakness or breathing difficulties).
Precautions and Warnings
Precautions & Warnings
- Gluconorm VG 0.5 Tablet should not be used in individuals with known hypersensitivity to any of its components.
- Patients with severe kidney impairment should avoid using this medication due to the risk of Metformin accumulation.
- Alcohol consumption should be limited as it increases the risk of hypoglycaemia and lactic acidosis.
- Pregnant women should consult their healthcare provider for alternative diabetes management options during pregnancy.
- Breastfeeding mothers should use Gluconorm VG 0.5 Tablet under medical supervision to ensure safety for the infant.
- Caution is advised when driving or operating machinery due to the potential effects of hypoglycaemia on concentration and alertness.
- Regular monitoring of liver function is recommended for patients on this medication due to potential risks associated with liver impairment.
- Consult a healthcare professional if experiencing symptoms such as abdominal pain or jaundice while on Gluconorm VG 0.5 Tablet.
FAQs
1. What is Gluconorm VG 0.5 Tablet used for?
Gluconorm VG 0.5 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are inadequately controlled with fewer medications.
2. Why are three medicines combined in one tablet?
The combination allows each ingredient to work through different mechanisms, addressing insulin deficiency, resistance, and delayed carbohydrate absorption.
3. Can Gluconorm VG 0.5 Tablet cause hypoglycaemia?
Yes, the Glimepiride component may lead to low blood sugar levels if meals are delayed or missed; maintaining regular meal timing can help mitigate this risk.
4. Should Gluconorm VG 0.5 Tablet be taken with food?
Yes, it is recommended to take this medication with meals to reduce gastrointestinal discomfort and enhance post-meal glucose control.
5. Does Voglibose reduce post-meal blood sugar?
Yes, Voglibose delays carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Is Gluconorm VG 0.5 Tablet safe for long-term use?
Yes, it is commonly prescribed for long-term diabetes management under regular monitoring of blood sugar levels.
7. Can alcohol be taken while using Gluconorm VG 0.5 Tablet?
Alcohol should be limited as it increases the risk of hypoglycaemia and may elevate the risk of lactic acidosis associated with Metformin.
Gluconorm VG 0.5 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are inadequately controlled with fewer medications.
2. Why are three medicines combined in one tablet?
The combination allows each ingredient to work through different mechanisms, addressing insulin deficiency, resistance, and delayed carbohydrate absorption.
3. Can Gluconorm VG 0.5 Tablet cause hypoglycaemia?
Yes, the Glimepiride component may lead to low blood sugar levels if meals are delayed or missed; maintaining regular meal timing can help mitigate this risk.
4. Should Gluconorm VG 0.5 Tablet be taken with food?
Yes, it is recommended to take this medication with meals to reduce gastrointestinal discomfort and enhance post-meal glucose control.
5. Does Voglibose reduce post-meal blood sugar?
Yes, Voglibose delays carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Is Gluconorm VG 0.5 Tablet safe for long-term use?
Yes, it is commonly prescribed for long-term diabetes management under regular monitoring of blood sugar levels.
7. Can alcohol be taken while using Gluconorm VG 0.5 Tablet?
Alcohol should be limited as it increases the risk of hypoglycaemia and may elevate the risk of lactic acidosis associated with Metformin.
Instructions
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
More Information
| SKU | 946012 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Gluconorm VG 0.5 Tablet is a comprehensive pharmaceutical formulation designed specifically for the management of type 2 diabetes mellitus. This innovative medication combines three well-established anti-diabetic agents, each with distinct and complementary mechanisms of action, aimed at improving blood glucose control in patients who struggle with multiple metabolic defects contributing to poor glycaemic control. The key components of Gluconorm VG 0.5 Tablet include Glimepiride, Metformin, and Voglibose. Glimepiride is a third-generation sulfonylurea that effectively stimulates insulin secretion from functional pancreatic beta cells. By binding to sulfonylurea receptors on the membranes of pancreatic beta cells, Gluconorm VG 0.5 Tablet facilitates the closure of ATP-sensitive potassium channels, leading to membrane depolarization, calcium influx, and subsequent insulin release. This action primarily aids in lowering both fasting and postprandial blood glucose levels. Metformin, another crucial ingredient in Gluconorm VG 0.5 Tablet, belongs to the biguanide class and is recognized as a first-line treatment for type 2 diabetes. It works by reducing hepatic gluconeogenesis, enhancing peripheral insulin sensitivity, and improving glucose utilization in muscle tissue. Unlike sulfonylureas, Metformin does not stimulate insulin secretion, thus presenting a low independent risk of hypoglycaemia when used alone. The third component, Voglibose, is an alpha-glucosidase inhibitor that operates in the small intestine by inhibiting enzymes responsible for carbohydrate breakdown. This mechanism delays glucose absorption after meals, significantly reducing postprandial blood glucose excursions. The combination of these three agents in Gluconorm VG 0.5 Tablet is particularly beneficial as it addresses three major contributors to hyperglycaemia: inadequate insulin secretion, insulin resistance, and excessive post-meal glucose absorption. Gluconorm VG 0.5 Tablet is typically prescribed when lifestyle modifications and simpler anti-diabetic regimens fail to achieve desired glycaemic targets, making it an essential option for effective diabetes management.
Uses & Benefits
- Gluconorm VG 0.5 Tablet provides triple mechanism glucose control by targeting insulin secretion, insulin sensitivity, and carbohydrate absorption simultaneously.
- This formulation improves fasting and post-meal sugar levels, ensuring better overall glycaemic control.
- Gluconorm VG 0.5 Tablet helps reduce glucose fluctuations, maintaining more stable daily blood sugar patterns.
- Convenient combination therapy reduces the pill burden compared to taking separate medicines.
- Supports long-term diabetes management by helping improve HbA1c levels when used regularly.
- Addresses multiple metabolic pathways, making it useful in progressive type 2 diabetes requiring intensified therapy.
- Gluconorm VG 0.5 Tablet is effective in managing blood sugar levels when lifestyle changes alone are insufficient.
- This medication is suitable for patients who require a comprehensive approach to diabetes management.
How Gluconorm VG 0.5 Tablet works
Gluconorm VG 0.5 Tablet works through three complementary anti-diabetic mechanisms that enhance glycaemic control.
- Glimepiride stimulates pancreatic beta cells to release insulin by closing ATP-sensitive potassium channels, which increases insulin availability.
- Metformin reduces hepatic glucose production, improves peripheral insulin sensitivity, and enhances glucose uptake by skeletal muscle.
- Voglibose inhibits intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and reducing postprandial glucose absorption.
- Together, these actions improve fasting glucose levels and long-term glycaemic control.
How to use Gluconorm VG 0.5 Tablet
- Gluconorm VG 0.5 Tablet should be taken exactly as prescribed by a healthcare professional.
- This medication is usually taken with meals to minimize gastrointestinal discomfort.
- Swallow the tablet whole with a sufficient amount of water; do not chew or crush it.
- Do not skip meals while taking Gluconorm VG 0.5 Tablet to maintain stable blood sugar levels.
- Maintain regular meal timing to optimize the effectiveness of this therapy.
- Monitor blood sugar levels regularly to assess the effectiveness of Gluconorm VG 0.5 Tablet.
- The daily dose may vary based on individual blood glucose levels and clinical response; follow your doctor's recommendations closely.
- Consult your healthcare provider for any adjustments in dosage or treatment duration based on your condition.
Lifestyle Advice
- Avoid skipping meals while taking Gluconorm VG 0.5 Tablet to maintain stable blood sugar levels throughout the day.
- Incorporate a balanced diet rich in whole grains, vegetables, and lean proteins to support overall health and diabetes management.
- Engage in regular physical activity to enhance insulin sensitivity and improve glycaemic control alongside medication use.
- Monitor HbA1c levels regularly to assess long-term blood sugar control and adjust treatment as necessary.
- Carry a source of glucose for immediate relief in case of hypoglycaemia symptoms such as dizziness or sweating.
Side Effects
Side Effects
- Common side effects of Gluconorm VG 0.5 Tablet include hypoglycaemia (low blood sugar), especially if meals are delayed or missed.
- Mild abdominal discomfort may occur during treatment initiation or dose adjustment.
- Flatulence is common due to delayed carbohydrate digestion caused by Voglibose.
- Nausea is usually mild and often improves over time as the body adjusts to the medication.
- Diarrhoea may frequently occur during early treatment with Metformin.
- Uncommon side effects include temporary loss of appetite and a metallic taste occasionally associated with Metformin use.
- Mild dizziness may occur, particularly during fluctuations in blood glucose levels.
- Serious side effects requiring immediate medical attention include severe hypoglycaemia (characterized by sweating, confusion, tremors) and lactic acidosis (indicated by severe weakness or breathing difficulties).
Precautions and Warnings
Precautions & Warnings
- Gluconorm VG 0.5 Tablet should not be used in individuals with known hypersensitivity to any of its components.
- Patients with severe kidney impairment should avoid using this medication due to the risk of Metformin accumulation.
- Alcohol consumption should be limited as it increases the risk of hypoglycaemia and lactic acidosis.
- Pregnant women should consult their healthcare provider for alternative diabetes management options during pregnancy.
- Breastfeeding mothers should use Gluconorm VG 0.5 Tablet under medical supervision to ensure safety for the infant.
- Caution is advised when driving or operating machinery due to the potential effects of hypoglycaemia on concentration and alertness.
- Regular monitoring of liver function is recommended for patients on this medication due to potential risks associated with liver impairment.
- Consult a healthcare professional if experiencing symptoms such as abdominal pain or jaundice while on Gluconorm VG 0.5 Tablet.
1. What is Gluconorm VG 0.5 Tablet used for?
Gluconorm VG 0.5 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are inadequately controlled with fewer medications.
2. Why are three medicines combined in one tablet?
The combination allows each ingredient to work through different mechanisms, addressing insulin deficiency, resistance, and delayed carbohydrate absorption.
3. Can Gluconorm VG 0.5 Tablet cause hypoglycaemia?
Yes, the Glimepiride component may lead to low blood sugar levels if meals are delayed or missed; maintaining regular meal timing can help mitigate this risk.
4. Should Gluconorm VG 0.5 Tablet be taken with food?
Yes, it is recommended to take this medication with meals to reduce gastrointestinal discomfort and enhance post-meal glucose control.
5. Does Voglibose reduce post-meal blood sugar?
Yes, Voglibose delays carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Is Gluconorm VG 0.5 Tablet safe for long-term use?
Yes, it is commonly prescribed for long-term diabetes management under regular monitoring of blood sugar levels.
7. Can alcohol be taken while using Gluconorm VG 0.5 Tablet?
Alcohol should be limited as it increases the risk of hypoglycaemia and may elevate the risk of lactic acidosis associated with Metformin.
Gluconorm VG 0.5 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are inadequately controlled with fewer medications.
2. Why are three medicines combined in one tablet?
The combination allows each ingredient to work through different mechanisms, addressing insulin deficiency, resistance, and delayed carbohydrate absorption.
3. Can Gluconorm VG 0.5 Tablet cause hypoglycaemia?
Yes, the Glimepiride component may lead to low blood sugar levels if meals are delayed or missed; maintaining regular meal timing can help mitigate this risk.
4. Should Gluconorm VG 0.5 Tablet be taken with food?
Yes, it is recommended to take this medication with meals to reduce gastrointestinal discomfort and enhance post-meal glucose control.
5. Does Voglibose reduce post-meal blood sugar?
Yes, Voglibose delays carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Is Gluconorm VG 0.5 Tablet safe for long-term use?
Yes, it is commonly prescribed for long-term diabetes management under regular monitoring of blood sugar levels.
7. Can alcohol be taken while using Gluconorm VG 0.5 Tablet?
Alcohol should be limited as it increases the risk of hypoglycaemia and may elevate the risk of lactic acidosis associated with Metformin.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
| SKU | 946012 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account